top of page
Search
  • rgrosslaw
    • Oct 1, 2016
    • 1 min read

RGLaw Appeals Rejection of Application Directed to a Vaccine Against Influenza


RGLaw secured a favorable result for its client for a patent application directed to Polyvalent Fusion Protein Vaccine Against Influenza. Upon receiving a Final Office Action, Roy Gross filed a Pre-Appeal Brief which successfully persuaded a three-person panel at the USPTO that the patent specification is enabling of the claims and that claimed invention is novel and non-obvious over the cited prior art. Issuance of a patent containing all pending claims is expected in due course


#rgrosslaw #appeal

27 views0 comments

Recent Posts

See All

RGrossLaw Issues 66 Utility Patents in 2018 and is listed as one of the Top Patent Firms in the United States. https://harrityllp.com/services/patent-analytics/top-patent-firms-2018/ Continued growth

The newly established Roy Gross Law Firm, LLC, ("RGLaw") is proud to announce the issuance of its first U.S. Patent on January 26, 2016 — U.S. Patent Number 9,242,003 entitled "Surface-Modified Heavy

bottom of page